Multidimensional Predictors of Balance in Healthy Young Adults
NCT07434830, Completed, Akdeniz University
Trial 9
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Multidimensional Predictors of Balance in Healthy Young Adults | ClinicalTrials.gov |
| NCT number | NCT07434830 | ClinicalTrials.gov |
| Status | Completed | ClinicalTrials.gov |
| Enrollment | 119 participants, actual | ClinicalTrials.gov |
| Lead sponsor | Akdeniz University | ClinicalTrials.gov |
| Conditions | Healthy Adult, Balance Assessment | ClinicalTrials.gov |
| Interventions | Participants did not receive any intervention as part of the study; they only underwent assessments. | ClinicalTrials.gov |
| First posted | 2026-02-27 | ClinicalTrials.gov |
| Last updated | 2026-02-27 | ClinicalTrials.gov |
Registered outcomes 12
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Stork Balance Test (Eyes Open and Eyes Closed) Time | At a single study visit (baseline) | Time (seconds) maintained in the Stork Balance Test under eyes-open and eyes-closed conditions. Higher values indicate better static balance. | ClinicalTrials.gov |
| Primary | Tandem Stance Test (Eyes Open and Eyes Closed) Time | At a single study visit (baseline) | Time (seconds) maintained in the Tandem Stance Test under eyes-open and eyes-closed conditions. Higher values indicate better static balance. | ClinicalTrials.gov |
| Primary | Y-Balance Test Composite Score (Right and Left) | At a single study visit (baseline) | Y-Balance Test composite score (%) for the right and left lower limbs, calculated from reach distances and normalized to limb length. Higher values indicate better dynamic balance. | ClinicalTrials.gov |
| Secondary | Foot Posture Index-6 (FPI-6) | Baseline (single assessment session) | Foot posture assessed using the Foot Posture Index-6. Outcome: total FPI-6 score (-12 to +12), with higher scores indicating a more pronated foot posture. | ClinicalTrials.gov |
| Secondary | Knee-to-Wall Test (KTW) | Baseline (single assessment session) | Ankle mobility was assessed with the Knee-to-Wall Test (KTW). In this test, functional dorsiflexion flexibility was measured using a tape measure placed on the tip of the foot while the participant attempted to touch the wall with the knee without heel lift. | ClinicalTrials.gov |
| Secondary | 30-Second Sit-to-Stand Test | Baseline (single assessment session) | Number of full sit-to-stand repetitions completed in 30 seconds. Higher counts indicate better functional lower-limb strength/endurance. | ClinicalTrials.gov |
| Secondary | Dominant Hand Grip Strength | Baseline (single assessment session) | General muscle strength was assessed via dominant hand grip strength measurement. Dominant hand grip strength measured using a hand dynamometer. Outcome: mean grip strength (kg) across three trials. Higher values indicate greater general muscle strength. | ClinicalTrials.gov |
| Secondary | Stroop Test | Baseline (single assessment session) | Cognitive performance was tested with the Stroop Test-Part 5. In this section, participants were required to name the ink color of incongruent color words rather than reading the words. Completion time was recorded with a stopwatch. | ClinicalTrials.gov |
| Secondary | Fat Mass (kilograms) measured by Bioelectrical Impedance Analysis | Baseline (single assessment session) | Fat mass is measured using bioelectrical impedance analysis (Tanita body composition analyzer) and reported in kilograms. | ClinicalTrials.gov |
| Secondary | Skeletal Muscle Mass (kilograms) measured by Bioelectrical Impedance Analysis | Baseline (single assessment session) | Skeletal muscle mass is measured using bioelectrical impedance analysis (Tanita body composition analyzer) and reported in kilograms. | ClinicalTrials.gov |
| Secondary | Bone Mass (kilograms) measured by Bioelectrical Impedance Analysis | Baseline (single assessment session) | Bone mass is measured using bioelectrical impedance analysis (Tanita body composition analyzer) and reported in kilograms. | ClinicalTrials.gov |
| Secondary | Total Body Water (kilograms) measured by Bioelectrical Impedance Analysis | Baseline (single assessment session) | Total body water is measured using bioelectrical impedance analysis (Tanita body composition analyzer) and reported in kilograms. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 1
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Stroop Color-Word Test | Secondary outcome | ConductCognition |
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)